J. Carl Craft

Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria

Susan A. Charman, Sarah Arbe‐Barnes, Ian Bathurst et al. · Proceedings of the National Academy of Sciences · 2011 · 376 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia

Stan Block, James Hedrick, Margaret R. Hammerschlag et al. · The Pediatric Infectious Disease Journal · 1995 · 342 citations

Pharmacy, Child Health, Infectious Diseases +17

A Randomized Trial of Clarithromycin as Prophylaxis against Disseminated<i>Mycobacterium avium</i>Complex Infection in Patients with Advanced Acquired Immunodeficiency Syndrome

Mark A. Pierce, Sheri L. Crampton, David Henry et al. · New England Journal of Medicine · 1996 · 296 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Review of pyronaridine anti-malarial properties and product characteristics

Simon L. Croft, Stephan Duparc, Sarah Arbe‐Barnes et al. · Malaria Journal · 2012 · 158 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic

Richard E. Chaisson, Philip Keiser, Mark A. Pierce et al. · AIDS · 1997 · 148 citations

Pharmacy, Infectious Diseases, Pharmacology +17